Eric Karas sold $250K of ARS Pharmaceuticals (SPRY)

Executed Jun 12, disclosed Jun 12, the same day.

Value, as filed

$250K

25,000 sh × $10.00

Executed

Jun 12

the trade date, as filed

Disclosed

Jun 12

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EK Eric Karas Chief Commercial Officer profile →

Eric Karas (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SPRY. The largest single filing was $250K of SPRY (25,000 sh × $10.00, as filed), executed Jun 12.

The name

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric Karas in SPRY

SPRYSALE ARS Pharmaceuticals, Inc. $255K
15,000 sh × $16.99
Exec Jul 1 2025
Filed Jul 3 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $240K
15,000 sh × $16.00
Exec Jun 18 2025
Filed Jun 20 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $140K
10,000 sh × $14.00
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $140K
10,000 sh × $14.00
Exec Sep 18 2024
Filed Sep 19 2024 · 5:30 PM ET